References
- Bahado-Singh R, Deren O, Oz U, et al. An alternative for women initially declining genetic amniocentesis: individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers. Am J Obstet Gynecol 1998;179:514–19
- Nyberg DA, Luthy DA, Resta RG, et al. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998;12:8–14
- Vergani P, Locatelli A, Piccoli MG, et al. Best second trimester sonographic markers for the detection of trisomy 21. J Ultrasound Med 1999;18:469–73
- DeVore GR. The role of fetal echocardiography in genetic sonography. Semin Perinatol 2003;27:160–72
- DeVore GR. Trisomy 21: 91% detection rate using second-trimester ultrasound markers. Ultrasound Obstet Gynecol 2000;16:133–41
- Devore GR. Genetic sonography: the historical and clinical role of fetal echocardiography. Ultrasound Obstet Gynecol 2010;35:509–21
- Luewan S, Yanase Y, Tongprasert F, et al. Fetal cardiac dimensions at 14-40 weeks' gestation obtained using cardio-STIC-M. Ultrasound Obstet Gynecol 2011;37:416–22
- Udomwan P, Luewan S, Tongsong T. Fetal aortic arch measurements at 14 to 40 weeks' gestation derived by spatiotemporal image correlation volume data sets. J Ultrasound Med 2009;28:1651–6
- Traisrisilp K, Tongprasert F, Srisupundit K, et al. Reference ranges for the fetal cardiac circumference derived by cardio-spatiotemporal image correlation from 14 to 40 weeks' gestation. J Ultrasound Med 2011;30:1191–6
- Tongprasert F, Srisupundit K, Luewan S, et al. Reference ranges of fetal aortic and pulmonary valve diameter derived by STIC from 14 to 40 weeks of gestation. Prenat Diagn 2011;31:439–45
- Chaoui R, Heling KS, Sarioglu N, et al. Aberrant right subclavian artery as a new cardiac sign in second- and third-trimester fetuses with Down syndrome. Am J Obstet Gynecol 2005;192:257–63
- Paladini D, Tartaglione A, Agangi A, et al. The association between congenital heart disease and Down syndrome in prenatal life. Ultrasound Obstet Gynecol 2000;15:104–8
- Cleves MA, Hobbs CA, Cleves PA, et al. Congenital defects among liveborn infants with Down syndrome. Birth Defects Res A Clin Mol Teratol 2007;79:657–63
- Russo MG, Pacileo G, Marino B, et al. Echocardiographic evaluation of left ventricular systolic function in the Down syndrome. Am J Cardiol 1998;81:1215–17
- Korbel JO, Tirosh-Wagner T, Urban AE, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA 2009;106:12031–6
- Barlow GM, Chen XN, Shi ZY, et al. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 2001;3:91–101
- Fuentes JJ, Pritchard MA, Planas AM, et al. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 1995;4:1935–44
- Prandini P, Deutsch S, Lyle R, et al. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet 2007;81:252–63
- Ripoll C, Rivals I, Ait Yahya-Graison E, et al. Molecular signatures of cardiac defects in Down syndrome lymphoblastoid cell lines suggest altered ciliome and Hedgehog pathways. PLoS One 2012;7:e41616